| Value | ₹200.0 Cr |
|---|
NSE filing, NSE: AFIL. Summary written from the filing by ALFA Finder's alert engine.
Akme Fintrade (India) Ltd: key numbers
- Share price
- ₹7.02
- Market cap
- ₹305.3 Cr
- Revenue (annual)
- ₹148.8 Cr
- Net profit (annual)
- ₹42.32 Cr
- P/E (TTM)
- 6.6×Sector 20.3×
- Promoter holding
- 38.94%-0.08% QoQ
- FII holding
- 0.35%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Akme Fintrade (India) Ltd
All →Akme Fintrade (India) Share Pledge
Promoter Manju Devi Jain pledged 1,14,50,000 Akme Fintrade shares (2.55%) to Upsurge Investment & Finance. Post-pledge encumbrance rises to 4.43% of share capital.
Akme Fintrade (India) Results Update
Akme Fintrade's press release shows H1 FY27 PAT up 19% and AUM crossing Rs. 1,000 crore. The unaudited results were approved by the board.
Akme Fintrade (India) Q2 FY27 Results: Net Profit ₹11.9 Cr, Up 19.0% YoY
Akme Fintrade (India) Ltd reported revenue from operations of ₹45.5 Cr (+30.4% YoY) and net profit of ₹11.9 Cr (+19.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹11.9 Cr · +19.0% YoY
Akme Fintrade (India) Preferential Issue
Akme Fintrade received NSE and BSE trading approval for 82 lakh preferentially-issued equity shares. Listed capital rose to Rs. 44.79 Crore post-approval.
Akme Fintrade (India) Convertible Warrants
Akme Fintrade received NSE and BSE trading approval for 82 lakh equity shares from preferential warrant conversion. Total listed capital rose to Rs. 44.79 crore post-allotment.
Akme Fintrade (India) Board Meeting Date
Akme Fintrade intimated that its Board will meet on October 30, 2026 to approve unaudited financial results for Q2 H1 FY27. Trading window remains closed until 48 hours post-announcement.
Other business update announcements
All →Zydus Lifesciences Business Update
Zydus Lifesciences' subsidiary presented Phase 2b trial data for investigational saroglitazar in MASH at AASLD 2026. The drug showed higher steatohepatitis resolution than placebo, but its safety and effectiveness for this use are not yet established.
Rajshree Sugars & Chemicals Business Update
Rajshree Sugars reported October 2026 operational data for its three sugar units. Sugar sales were 17,849 MT, with no cane crushed during the month.
Fino Payments Bank Business Update
Fino Payments Bank's October 2026 update showed deposits crossing Rs 3,000 Crore for the first time. Loan referral disbursals rose 316% year-on-year to Rs 301 Crore.
Ugar Sugar Works Business Update
Ugar Sugar Works has informed the exchanges that crushing for the 2026-27 season started at its Ugar Unit on 06 Nov 2026. Crushing will ramp up to full capacity over time.
Aarti Drugs Business Update
Aarti Drugs disclosed that the US FDA inspected its subsidiary Pinnacle Life Science's Baddi plant on 2-6 November 2026 and issued three Form 483 observations. The company states there is no financial or operational impact.
GSM Foils Business Update
GSM Foils Limited reported Net Sales of Rs. 14,63,47,636 for October 2026, with April-October cumulative sales of Rs. 1,59,69,98,607. The monthly sales update is filed under Regulation 30.
- Value
- ₹14.63 Cr